Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

724
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
724
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

305
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
305
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

314
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
314
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

177
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

123
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

375
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
375

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A precautionary tale of lenacapavir drug-drug interactions: A case series of two persons living with HIV receiving long-acting injections.

International journal of STD & AIDS·2026
Same author

Clinical Characteristics and Outcomes of Older Patients Admitted to the Cardiac Intensive Care Unit.

JACC. Advances·2026
Same author

Comparative outcomes of intra-aortic balloon pump versus impella in non-myocardial infarction cardiogenic shock: A National Inpatient Sample Database analysis.

JHLT open·2026
Same author

The impact of race and sex on recent mortality trends after coronary artery bypass grafting.

JTCVS open·2026
Same author

Impact of In-Hospital STEMI on Reperfusion Times and Clinical Outcomes.

Circulation. Cardiovascular interventions·2026
Same author

Physics-Based Models of Extraction Kinetics in Solvent-Swollen Polymers: Using Non-Exhaustive Extractions to Estimate Total Extractable Quantities.

Journal of biomedical materials research. Part B, Applied biomaterials·2025

Related Experiment Video

Updated: May 6, 2026

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
15:45

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice

Published on: February 10, 2013

17.4K

Reflections on a Dobutamine Shortage in an Academic Health System: A Roadmap for Risk Reduction.

Melissa H Chouinard, Natalie L Nguyen, Joshua A Young

    Joint Commission Journal on Quality and Patient Safety
    |January 15, 2025
    PubMed
    Summary

    Drug shortages are common. This strategy managed dobutamine shortages using technology, waste reduction, and supply centralization, ensuring patient access. This model can help other health systems.

    More Related Videos

    Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
    07:41

    Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

    Published on: March 17, 2022

    2.4K
    Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
    09:36

    Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

    Published on: September 24, 2020

    2.5K

    Related Experiment Videos

    Last Updated: May 6, 2026

    Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
    15:45

    Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice

    Published on: February 10, 2013

    17.4K
    Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
    07:41

    Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

    Published on: March 17, 2022

    2.4K
    Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
    09:36

    Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

    Published on: September 24, 2020

    2.5K

    Area of Science:

    • Pharmacology
    • Health Systems Management
    • Information Technology in Healthcare

    Background:

    • Increasing frequency and severity of drug shortages pose significant challenges to healthcare delivery.
    • Dobutamine is a critical medication often affected by supply chain disruptions.
    • Academic health systems require robust strategies to manage drug scarcity.

    Purpose of the Study:

    • To describe an interdisciplinary strategy for managing a nationwide dobutamine shortage.
    • To outline an approach for ensuring consistent supply of critical medications during shortages.
    • To provide a model for academic health systems facing drug scarcity.

    Main Methods:

    • Leveraging information technology resources for supply chain management.
    • Implementing waste minimization protocols to conserve existing stock.
    • Centralizing supply chain operations for efficient distribution.
    • Developing an interdisciplinary team for coordinated response.

    Main Results:

    • Successfully maintained a consistent supply of dobutamine for patients requiring it most.
    • Demonstrated the effectiveness of an integrated approach combining technology, conservation, and centralization.
    • Minimized disruption to patient care despite nationwide drug shortage.

    Conclusions:

    • The described interdisciplinary strategy effectively managed a dobutamine shortage in an academic health system.
    • Information technology, waste reduction, and supply centralization are key components for managing drug shortages.
    • This model offers a scalable solution for health systems to navigate future drug scarcity.